Clinical Trials on Cardiorenal Syndrome Type 1

Total 7017 results

The Eye Center and The Eye Foundation for Research...

Completed

Tyrosine Hydroxylase Antibody Levels in Autoimmune Polyglandular Syndrome Type 1 Associated Keratitis

Autoimmune Polyglandular Syndrome Type I | Autoimmune Keratitis
Ferring Pharmaceuticals

Completed

A Study of Terlipressin in Patients With Hepatorenal Syndrome Type 1 (HRS)

Hepatorenal Syndrome Type 1

Japan
Hillel Yaffe Medical Center

Unknown

Cardiorenal Syndrome in End-Stage Kidney Disease

Heart Disease | End-stage Renal Disease | Cardiorenal Syndrome

Israel
McGill University Health Centre/Research Institute...
CHU de Quebec-Universite Laval

Unknown

Circulating Extracellular Vesicles Released by Human Islets of Langerhans

Type2 Diabetes | Islet Cell Transplantation | Type1 Diabetes Mellitus

Canada
National Institute of Allergy and Infectious Diseases...

Completed

Study of Immune Responses and Safety of Recombinant Human CD40 Ligand in Patients With X-Linked Hyper-IgM Syndrome

Immunoproliferative Disorder

United States
Janssen Sciences Ireland UC

Completed

A Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed Dose Combination (FDC) Versus a Regimen Consisting of Darunavir/Cobicistat FDC With Emtricitabine/Tenofovir Disoproxil Fumarate FDC in Treatment-naive HIV Type 1 Infected Subjects

Immunodeficiency Virus Type 1, Human

United States, France, Poland, United Kingdom, Belgium, Germany, Spain, Canada, Russian Federation, Puerto Rico
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Azacitidine and Pembrolizumab in Treating Patients With Myelodysplastic Syndrome

Myelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | IPSS Risk Category Intermediate-1

United States
Helse Nord-Trøndelag HF
Norwegian University of Science and Technology; St. Olavs Hospital

Completed

Implementation of Telerehabilitation In Support of HOme-based Physical Exercise for Heart Failure (ITISHOPE4HF)

Chronic Kidney Diseases | Heart Failure, Diastolic | Heart Failure, Systolic | Cardiorenal Syndrome

Norway
University Hospital, Grenoble
ResMed; Société francophone de pneumologie de langue francaise

Completed

Effect of Sleep Apnea Treatment on Type 1 Diabetes (DIADEME)

Type 1 Diabetes | Sleep Apnea Syndrome

France
Leiden University Medical Center
Andaluz Health Service

Completed

"POWER2DM Evaluation Campaign" (POWER2DMEC)

Diabetes Mellitus | Health Behavior | Self Efficacy | Type2 Diabetes Mellitus | Type1 Diabetes Mellitus

Netherlands, Spain
Tibotec Pharmaceuticals, Ireland

Completed

TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.

HIV Infections | HIV-1 | Human Immunodeficiency Virus Type 1

United States, Australia, France, United Kingdom, Taiwan, Spain, Argentina, Portugal, Romania, South Africa, Canada, Denmark, Sweden, Netherlands, Brazil, Puerto Rico, Austria, Russian Federation, Thailand, Mexico
Postgraduate Institute of Medical Education and...

Completed

Terlipressin Infusion Alone Vs Terlipressin With Noradrenaline Infusion In The Treatment of Hepatorenal Syndrome Type 1

Type 1 HEPATO RENAL SYNDROME(HRS)

India
Second Affiliated Hospital of Guangzhou Medical...

Unknown

Islet Allotransplantation for Type 1 Diabetic Patients

Type 1 Diabetic

China
Bristol-Myers Squibb

Completed

Bioequivalence Study of Individual Atazanavir and Cobicistat Compared With Atazanavir in Fixed-dose Combination With Cobicistat (Atazanavir)

Human Immunodeficiency Virus Type 1 (HIV-1)

United States
Bristol-Myers Squibb

Completed

Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy Participants

HIV Infections | Human Immunodeficiency Virus Type 1 (HIV-1)

United States, Netherlands
University of Giessen

Completed

Renal Venous Flow and Cardiac Surgery-associated Acute Kidney Injury

Acute Kidney Injury | Cardiorenal Syndrome

Germany
Eledon Pharmaceuticals

Withdrawn

Safety, Tolerability, and Efficacy of Immunomodulation With AT-1501 in Combination With Transplanted Islet Cells in Adults With Brittle T1D

Brittle Type 1 Diabetes Mellitus

United States
National Cancer Institute (NCI)

Active, not recruiting

Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Myelodysplastic Syndrome With Excess Blasts | Chronic Myelomonocytic Leukemia-1 | Chronic Myelomonocytic Leukemia-2 | Myelodysplastic Syndrome With Excess Blasts-1 | Myelodysplastic Syndrome/Acute Myeloid Leukemia

Canada, United States
University of Utah
University of British Columbia; Children's Hospital Medical Center, Cincinnati and other collaborators

Terminated

Vitamin D Supplementation for Adults With Neurofibromatosis Type 1 (NF1) (VitDBoneNF1)

Neurofibromatosis Type 1 (NF1)

United States, Canada
National Institute of Allergy and Infectious Diseases...
PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)

Completed

Tocilizumab (TCZ) in New-onset Type 1 Diabetes (EXTEND)

Type 1 Diabetes Mellitus | T1DM | T1D | New-onset Type 1 Diabetes Mellitus

United States, Australia
University of Padova

Unknown

Terlipressin Given As I.V. Boluses Versus Terlipressin Given As Continuous Intravenous Infusion In Patients With Cirrhosis And Type 1 Hepatorenal Syndrome

Cirrhosis | Type 1 Hepatorenal Syndrome

Italy
University of Giessen

Completed

Predictive Value of Renal Venous Flow Profiles for Adverse Outcomes in Right Heart Failure

Heart Failure | Pulmonary Hypertension | Cardiorenal Syndrome

Germany
University of Alabama at Birmingham

Completed

MEK Inhibitor PD-0325901 Trial in Adolescents and Adults With NF1 (MEK Inhibitor)

Neurofibromatosis Type 1 and Growing or Symptomatic, Inoperable PN

United States
Freeman-Sheldon Research Group, Inc.

Terminated

Survey Study and Records Review of Treatment Outcomes in Freeman-Sheldon Syndrome (STOP-FSS)

Craniofacial Abnormalities | Arthrogryposis | Freeman-Sheldon Syndrome | Arthrogryposis Distal Type 2A | Whistling Face Syndrome | Craniocarpotarsal Dysplasia | Craniocarpotarsal Dystrophy | Freeman-Sheldon Syndrome Variant | Sheldon-Hall Syndrome | Arthrogryposis Distal Type 2B | Gordon Syndrome | Arthrogryposis... and other conditions

United States
Shanghai Changzheng Hospital

Recruiting

Allogeneic Regenerative Islet Transplantation for the Treatment of Brittle Type 1 Diabetes Mellitus

Brittle Type 1 Diabetes Mellitus

China
Procyrion
Procyrion Australia Pty Ltd

Completed

The Aortix CRS Pilot Study

Heart Failure | Heart Failure, Diastolic | Cardio-Renal Syndrome | Heart Failure, Systolic | Heart Failure; With Decompensation | Heart Failure，Congestive | Cardiorenal Syndrome

United States, Australia
University of Virginia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Neural-net Artificial Pancreas (NAP) (NAP)

Type1 Diabetes

United States
Air Liquide Santé International

Completed

Evaluation of Satisfaction Regarding Home Healthcare Provider (HHP) Management of Type 1 Diabetic Patients Using a Closed-loop Automatic Insulin Delivery System (SATURN)

Diabetes type1

France
Yale University
Harvard University

Completed

Yale-Harvard Hotel-based Closed-Loop Studies in Children (HY-GRAID) (HY-GRAID)

Type1 Diabetes

United States
Capillary Biomedical, Inc.

Completed

"FEXIS": (Feasibility of an Extended Wear CSII Set in Participants With T1DM) (FEXIS)

Diabetes Mellitus, Type 1 | Type 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Insulin-Dependent, 1

Australia
University of Colorado, Denver
Massachusetts General Hospital; Beta Bionics, Inc.

Completed

Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via Telehealth

Diabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditions

United States
Merck Sharp & Dohme LLC

Completed

Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)

Myelodysplastic Syndromes | Anemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndromes (MDS) | Chronic Myelomonocytic Leukemia (CMML) | Low to Intermediate-1 MDS

United States, France
Centre Hospitalier Universitaire de Nice

Recruiting

T1D Closed-loop and Physical Activity

Diabetes type1

France
University of Surrey
Medical University of Graz; KU Leuven; University of Cambridge; UK Civil Aviation... and other collaborators

Recruiting

Safe Use of New Technologies in Diabetes in Flight (SUNDIF)

Type1 Diabetes

United Kingdom
Sidra Medical and Research Center

Completed

Simple Initiation of Advanced Hybrid Closed Loop System (780GGS)

Diabetes type1

Qatar
Aristotle University Of Thessaloniki

Completed

Effect of Dual-wave Insulin Bolus on Postprandial Glycaemia

Type1 Diabetes

Greece
Sidney Kimmel Cancer Center at Thomas Jefferson...
Celgene Corporation

Terminated

A Dose Range Finding Study of Lenalidomide in Non-5q Chromosome Deletion in Low and Intermediate Risk Myelodysplastic Syndrome (MDS) Patients

Myelodysplastic Syndrome | MDS | Low to Intermediate-1 MDS | Non-deletion 5q

United States
Spiden AG
DCB Research AG

Completed

A Pilot Study to Assess the Feasibility of a Novel Non-invasive Technology to Measure Changing Blood Glucose Levels in Adults With Type-1 Diabetes Mellitus

Type 1 Diabetes Mellitus | Type 1 Diabetes Mellitus With Hypoglycemia | Type 1 Diabetes Mellitus With Hyperglycemia

Switzerland
Poznan University of Medical Sciences

Unknown

The Influence of Partial Remission Phase of Type 1 Diabetes on Patient Outcome (POZREM)

Diabetes Mellitus Type 1 | Remission of Type 1 Diabetes | Chronic Complications of Diabetes

Poland
Joslin Diabetes Center
Cambridge Medical Technologies, LLC

Completed

PRECISION Study: Evaluating the Accuracy of the LabPatch Continuous Glucose Monitor

Type 2 Diabetes Mellitus | Type1 Diabetes Mellitus

United States
Jerry Vockley, MD, PhD
Ultragenyx Pharmaceutical Inc

No longer available

Treatment With UX007 for a Single Patient With GLUT1 Deficiency Syndrome

Glucose Transporter 1 Deficiency Syndrome

United States
Vitaflo International, Ltd

Withdrawn

Evaluation of Krio in Children and Adults With Epilepsy (Krio)

Epilepsy | Glucose Transporter Type 1 Deficiency Syndrome | Ketogenic Dieting
Hadassah Medical Organization

Withdrawn

Assessment of a Health Informatics System on Insulin-treated Diabetic Patients

Type 1 or 2 Diabetics
Hadassah Medical Organization

Unknown

GLP-1 Analogue Treatment in Uncontrolled Type 1 Diabetic Patients

Uncontrolled Type 1 Diabetic Patients
Annesofie Lunde Jensen

Completed

DiabetesFlex - Patient Involvement and Patient-reported Outcome Measures in Type 1 Diabetes

Type1 Diabetes Mellitus

Denmark
Lenar Yessayan

Suspended

SCD for CRS in Congestive Heart Failure (CHF) (No Left Ventricular Assist Device)

Heart Failure | Renal Failure | Chronic Systolic Heart Failure | Cardiorenal Syndrome

United States
Children's Hospital Los Angeles

Not yet recruiting

CGM Academy for Youth With Type 1 Diabetes

Type1 Diabetes
Michael Tsoukas
Adocia

Recruiting

Safety and Efficacy of BC LisPram

Type1 Diabetes Mellitus

Canada
Universitaire Ziekenhuizen KU Leuven
University Hospital, Ghent; Universitair Ziekenhuis Brussel; University Hospital... and other collaborators

Completed

Closed-loop Insulin Delivery in Pregnant Women With Type 1 Diabetes (CRISTAL)

Type1 Diabetes

Belgium, Netherlands
Imperial College London

Completed

Optimising Consultation Summaries to Promote Good Health (ONSET)

Type1 Diabetes

United Kingdom

Clinical Trials on Cardiorenal Syndrome Type 1

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations